Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 12.37% |
| 4 | Industrials | 10.61% |
| 5 | Consumer Staples | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AHGP
1426
DELISTED
Alliance Holdings GP
AHGP
| $3.59M | 0.01% |
55,342
+49,350
| +824% | +$3.16M |
|
1427
MakeMyTrip
MMYT
$5.7B
| $3.57M | 0.01% |
+101,720
| New | +$2.59M |
|
|
HSII
1428
DELISTED
Heidrick & Struggles
HSII
| $3.56M | 0.01% |
192,400
+39,898
| +26% | +$748K |
|
1429
Provident Financial
PROV
$112M
| $3.55M | 0.01% |
244,397
-6,603
| -3% | -$95.1K |
|
1430
Heartland Express
HTLD
$991M
| $3.54M | 0.01% |
+166,033
| New | +$3.59M |
|
1431
MSCI
MSCI
$41.4B
| $3.54M | 0.01% |
77,121
+40,400
| +110% | +$1.74M |
|
|
CYT
1432
DELISTED
CYTEC INDS INC
CYT
| $3.52M | 0.01% |
66,800
-155,000
| -70% | -$7.66M |
|
1433
Reading International Class A
RDI
$37.3M
| $3.52M | 0.01% |
412,300
+110,000
| +36% | +$869K |
|
1434
Sumitomo Mitsui Financial
SMFG
$167B
| $3.5M | 0.01% |
412,891
+214,191
| +108% | +$1.76M |
|
1435
Wintrust Financial
WTFC
$11B
| $3.5M | 0.01% |
76,000
-69,300
| -48% | -$3.14M |
|
|
FONR
1436
DELISTED
Fonar
FONR
| $3.49M | 0.01% |
286,141
-91,375
| -24% | -$1.32M |
|
|
TESO
1437
DELISTED
Tesco Corp
TESO
| $3.49M | 0.01% |
163,500
-33,495
| -17% | -$686K |
|
1438
Patterson-UTI
PTEN
$4.32B
| $3.48M | 0.01% |
99,738
-793,296
| -89% | -$26M |
|
|
EMCI
1439
DELISTED
EMC INS Group Inc
EMCI
| $3.48M | 0.01% |
169,811
+6,588
| +4% | +$144K |
|
1440
RCM Technologies
RCMT
$247M
| $3.48M | 0.01% |
547,200
+3,606
| +0.7% | +$23.4K |
|
|
RPXC
1441
DELISTED
RPX Corporation
RPXC
| $3.48M | 0.01% |
195,930
+77,918
| +66% | +$1.29M |
|
1442
Alamo Group
ALG
$2.03B
| $3.46M | 0.01% |
64,000
+9,544
| +18% | +$511K |
|
1443
Credicorp
BAP
$30.3B
| $3.45M | 0.01% |
+22,200
| New | +$3.33M |
|
1444
Perdoceo Education
PRDO
$1.97B
| $3.44M | 0.01% |
736,062
+136,766
| +23% | +$791K |
|
1445
Mind CTI
MNDO
$20.6M
| $3.44M | 0.01% |
1,457,600
+79,700
| +6% | +$168K |
|
|
HBI
1446
DELISTED
Hanesbrands
HBI
| $3.43M | 0.01% |
139,200
-1,492,800
| -91% | -$30.8M |
|
1447
ORIX
IX
$43.6B
| $3.42M | 0.01% |
206,000
-161,330
| -44% | -$2.46M |
|
|
EQU
1448
DELISTED
EQUAL ENERGY LTD COM
EQU
| $3.42M | 0.01% |
630,285
+25,073
| +4% | +$127K |
|
|
THR
1449
DELISTED
Thermon Group Holdings
THR
| $3.41M | 0.01% |
129,550
+82,000
| +172% | +$2M |
|
|
ELX
1450
DELISTED
EMULEX CORP
ELX
| $3.4M | 0.01% |
597,200
+30,970
| +5% | +$184K |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.